Abstract:Introduction Cardiomyopathy causes ∼12.1% of pregnancy-related maternal mortality. Dilated cardiomyopathy(DCMP) in pregnancy is often either already known or discovered in the 2nd trimester as hemodynamic changes begin. Management is challenging as guideline directed medical therapy for heart failure with reduced ejection fraction is contraindicated in pregnancy. Antepartum cardiogenic shock(reported incidence ∼17%) significantly worsens outcomes. We describe using an Impella 5.5 micro-axial pump to successfully support a pregnancy complicated by DCMP and cardiogenic shock(CS). Clinical Case A 27-year-old gravida 3, parity 2 presented with CS in week 24 of pregnancy. Symptoms manifested around week 16 and progressively worsened. She was orthopneic and had anasarca. Lactic acid at presentation was 7.5mmol/L. Labs were otherwise unremarkable. Right heart catheterization revealed RA pressure of 15mmHg, PA pressure of 64/36mmHg (mean 45mmHg), cardiac index of 1.6L/min/m2 and systemic vascular resistance >1300 dyne/cm5. PCWP could not be measured due to severe PA dilation. Echocardiogram revealed biventricular dilation with an LVEF<20%, LVEDd 7.8cm & severe mitral regurgitation. She was initiated on dobutamine but transitioned to milrinone for more effective vasodilation. She received aggressive diuresis. Anasarca improved but elevated PA pressures persisted. Fetal monitoring was performed by the maternal-fetal medicine/obstetric team. Due to her critical condition and body habitus, assessing fetal growth accurately was challenging although there was restricted growth at baseline. Cardiac index improved modestly and a decision was made to escalate support to an axillary Impella 5.5 to augment flow to the mother and, hopefully, placental flow to the fetus. She underwent a successful cesarean delivery 4 weeks after Impella placement. The Impella remained for 3 weeks post-partum hoping for ventricular recovery. Hope unrealized, she underwent an HM3 LVAD placement. Cardiac biopsy at that time showed disarrayed hypertrophic cardiomyocytes without interstitial fibrosis or infarction. She remains independent and functional at follow-up. Her daughter is home after 3 months in the NICU. Discussion Impella is a percutaneous LVAD used to support patients with CS. Its use in pregnancy is rare and safety data in this population is limited. Pregnancy in patients with DCMP is potentially dangerous given the increased demands on the cardiovascular system. Treating CS in pregnancy is complex and requires a multidisciplinary approach. Conventionally, options were early delivery or termination. There have been few case reports describing Impella use in pregnancy with CS. To our knowledge this is the first reported case using an axillary Impella 5.5 to support a patient for several weeks to achieve cardiac stability as well as allow fetal maturity. The axillary placement of the Impella 5.5 also helped the patient maintain ambulation. Using an Impella in pregnancy requires careful consideration of potential risks and benefits for mother and fetus, and close monitoring by a multidisciplinary team.

Perioperative Management of an Obstetric Patient with Eisenmenger Syndrome and Pre-Eclampsia Using Milrinone

Management and outcomes of pulmonary artery hypertension and Eisenmenger syndrome during pregnancy: a prospective observational cohort study

[Eisenmenger's syndrome in pregnancy: a case report and literature review]

Perioperative Management of Parturient Women With Severe Pulmonary Arterial Hypertension Secondary to Atrial Septal Defect

Postoperative Treatment for Pregnant Patients with Eisenmenger Syndrome in ICU

Management of acutely decompensated chronic thromboembolic pulmonary hypertension in late pregnancy: a case report

Pulmonary hypertension and pregnancy: a series of eight cases

Anaesthetic management of a patient with severe pulmonary hypertension, moderate tricuspid regurgitation and moderate right ventricular dysfunction presenting for a dilation and curettage

Cesarean Section in a Morbidly Obese Patient With Severe Preeclampsia and Pulmonary Edema: A Case Report

Successful multimodality management of severe pulmonary arterial hypertension during pregnancy with VA-ECMO and atrial septostomy using stent

Cesarean Section in a Group 1 Pulmonary Hypertension Parturient Patient: A Case Report

Chronic Thromboembolic Pulmonary Hypertension, Pregnancy, and a Pulmonary Endarterectomy: A Rare Challenge

Treatment strategy of pregnant women with Eisenmenger's syndrome

Successful rescue of antepartum eclampsia in a Chinese patient: Case report

Multidisciplinary Team Managements and Clinical Outcomes in Patients With Pulmonary Arterial Hypertension During the Perinatal Period

Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators

Milrinone in the treatment of Persistent Pulmonary Hypertension of the Newborn: A Case Series

Critical care management of pulmonary arterial hypertension in pregnancy: the pre-, peri- and post-partum stages

One Pump For Two Hearts - A Single-center Experience With An Impella 5.5 Micro-axial Pump In A Peripartum Patient With Cardiogenic Shock

Pregnancy and pulmonary hypertension: a practical approach to management

Diagnosis and Treatment of Eisenmenger's Syndrome During Pregnancy